References
- Shrewsbury SB Cook RO Taylor G Edwards C Ramadan NM Safety and pharmacokinetics of dihydroergotamine mesylate administered via a Novel (Tempo) inhaler Headache 2008 48 3 355 367 18179563
- Shrewsbury SB Kori S Miller SD Pedinoff A Weinstein S Randomized, double blind, placebo controlled study of the safety, tolerability and pharmacokinetics of MAP0004 (orally-inhaled DHE) in adult asthmatics Curr Med Res Opin 2008 24 7 1977 1985 18534051
- Forst A Febbraro S Kellerman D An open-label, two-period crossover study comparing the pharmacokinetics and tolerability of LEVADEX™ (MAP0004, orally inhaled DHE) and intravenous DHE (DHE45®) in smoking and non-smoking adult volunteers Headache 2011 51 Suppl 1 17 Abstract P31
- Kellerman D Kori S Forst A Lack of drug interaction between the migraine drug MAP0004 (orally inhaled dihydroergotamine) and a CYP3A4 inhibitor in humans Cephalalgia 2012 1 32 2 150 158 22174351
- Aurora SK Rozen TD Kori S Shrewsbury SB A randomized, double blind, placebo controlled study of MAP0004 in adult patients with migraine Headache 2009 49 6 826 837 19545249
- Aurora SK Silberstein SD Kori SH MAP0004, orally inhaled DHE: a randomized, controlled study in the acute treatment of migraine Headache 2011 51 4 507 517 21457235
- Lang RM Bierig M Devereux RB Chamber Quantification Writing Group; American Society of Echocardiography’s Guidelines and Standards Committee; European Association of Echocardiography Recommendations for chamber quantification: a report from the American Society of Echocardiography’s Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology J Am Soc Echocardiogr 2005 18 12 1440 1463 16376782
- Milan A Magnino C Veglio F Echocardiographic indexes for the non-invasive evaluation of pulmonary hemodynamics J Am Soc Echocardiogr 2010 23 3 225 239 20206827
- Rudski LG Lai WW Afilalo J Guidelines for the echocardiographic assessment of the right heart in adults: a report from the American Society of Echocardiography, a registered branch of the European Society of Cardiology, and the Canadian Society of Echocardiography J Am Soc Echocardiogr 2010 23 7 685 713 20620859
- Fisher MR Criner GJ Fishman AP NETT Research Group Estimating pulmonary artery pressures by echocardiography in patients with emphysema Eur Respir J 2007 30 5 914 921 17652313
- Fisher MR Forfia PR Chamera E Accuracy of Doppler echocardiography in the hemodynamic assessment of pulmonary hypertension Am J Respir Crit Care Med 2009 179 7 615 621 19164700
- Naeije R Torbicki A More on the non-invasive diagnosis of pulmonary hypertension: Doppler echocardiography revisited Eur Respir J 1995 8 9 1445 1449 8575567
- Tramarin R Torbicki A Marchandise B Laaban JP Morpurgo M Doppler echocardiographic evaluation of pulmonary artery pressure in chronic obstructive pulmonary disease. A European multicentre study. Working Group on Noninvasive Evaluation of Pulmonary Artery Pressure. European Office of the World Health Organization, Copenhagen Eur Heart J 1991 12 2 103 111 2044542
- Subhedar NV Shaw NJ Intraobserver variation in Doppler ultrasound assessment of pulmonary artery pressure Arch Dis Child Fetal Neonatal Ed 1996 75 1 F59 F61 8795360
- Humbert H Cabiac MD Dubray C Lavène D Human pharmacokinetics of dihydroergotamine administered by nasal spray Clin Pharmacol Ther 1996 60 3 265 275 8841149
- Cook RO Shrewsbury SB Ramadan NM Reduced adverse event profile of orally inhaled DHE (MAP0004) vs IV DHE: potential mechanism Headache 2009 49 10 1423 1434 19751370